Development of the infants given tadalafil treatment in utero.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028773

Enrollment

Registered

2017-08-22

Start date

2017-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal growth restriction and hypertensive pregnancy disorders

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Written informed consent

Exclusion criteria

Exclusion criteria: Attending physician decides to entry inappropriate.

Design outcomes

Primary

Measure	Time frame
Ratio of the infants with less than 70 of DQ score.	—

Secondary

Measure	Time frame
1. Effect of tadalafil treatment on DQ score. 2. Effect of maternal complications on ratio of the infants with less than 70 of DQ score. 3. Effect of maternal complications on DQ score. 4. Effect of perinatal factors on ratio of the infants with less than 70 of DQ score. 5. Effect of perinatal factors on DQ score.	—

Countries

Japan

Outcome results